Charles Wade

9PUBLICATIONS
59CO-AUTHORS
Gene and molecular therapyDisease surveillanceNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Speech pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

|Jun 26, 2026
The clinical, radiological and genetic spectrum AARS2-related leukoencephalopathy: a case series of 15 patients and review of the literature.

|May 21, 2026
From Uncertainty to Pathogenicity: Resolving a CSF1R Variant of Uncertain Significance Using Long-Read Transcriptomics.

|Dec 29, 2025
Prion disease: An unlikely MS mimic.

Charles Wade

|Nov 27, 2025
The ABILHAND-23 Patient Reported Outcome Measure in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Analysis With the Nine Hole Peg Test.

Sean Apap Mangion, Charles Wade, Tom Williams

|Jul 09, 2025
Executive Dysfunction and Disability in SPMS: Predictive Value of the Frontal Assessment Battery in the UCLH MS-STAT2 Cohort.

Charles Wade, Anisha Doshi, Sean Apap Mangion

Pageof 2

Frequent Collaborators

4 joint publications

Tom Williams

3 joint publications

Henry Houlden

3 joint publications

David S Lynch

3 joint publications

Sean Apap Mangion